文献速递泌尿生殖腹部MR

磁共振成像对前列腺癌的预测能力及其在PI-RADS≥3病灶MRI靶向活检中的临床意义

Predictive ability of magnetic resonance imaging (MRI) for detecting prostate cancer and its clinical significance in MRI-targeted biopsy for prostate imaging reporting and data system (PI-RADS) ≥3 lesions.
PubMed 文献 · Clin Radiol · 2024-10-19

回顾性分析364例PI-RADS v2.1评分≥3且行认知MRI靶向活检的患者,其中良性226例(62.1%)、临床无显著前列腺癌75例(20.6%)、临床显著前列腺癌63例(17.3%)。多因素分析显示仅MRI参数(PI-RADS 4和5病灶、较低ADC值、较高ADCCoV值)是区分前列腺癌与良性病变的独立危险因素,但无MRI征象对临床显著前列腺癌有显著预测力,总PSA是唯一独立危险因素。作者认为MRI数据可预测前列腺癌但不能预测临床显著前列腺癌。

要点

  • PI-RADS 4和5病灶是前列腺癌的独立预测因素(OR分别为12和73)。
  • 较低ADC值和较高ADCCoV值是前列腺癌的独立预测因素。
  • 无MRI征象对临床显著前列腺癌有显著预测力,总PSA为唯一独立危险因素。

核心结论

  • MRI数据可预测前列腺癌但不能预测临床显著前列腺癌。

研究设计与样本

  • 回顾性分析364例PI-RADS v2.1评分≥3且行认知MRI靶向活检的患者,评估人口学、生化及影像学特征(包括ADC和ADCCoV值)。

关键影像表现/征象

  • MRI参数中PI-RADS 4病灶(OR 12,p<0.001)和PI-RADS 5病灶(OR 73,p=0.008)是前列腺癌独立危险因素。
  • 较低ADC值(OR 0.996,p=0.041)和较高ADCCoV值(OR 1.07,p=0.003)是前列腺癌独立危险因素。

诊断标准与关键数值

  • 区分前列腺癌与良性病变的多因素分析:PI-RADS 4病灶OR 12(p<0.001),PI-RADS 5病灶OR 73(p=0.008),ADC值OR 0.996(p=0.041),ADCCoV值OR 1.07(p=0.003)。
  • 临床显著前列腺癌的多因素分析:总PSA OR 1.17(p=0.019),为唯一独立危险因素;无MRI征象有显著预测力。

临床应用与阅片要点

  • 在PI-RADS≥3病灶的MRI靶向活检前,PI-RADS 4和5病灶、较低ADC值及较高ADCCoV值可提示前列腺癌风险。
  • MRI征象对临床显著前列腺癌无显著预测力,总PSA是唯一独立危险因素。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: Identifying the index lesion in prostate cancer (PCa) is vital for its treatment. Therefore, various coefficients and parameters are used to improve the diagnostic accuracy of magnetic resonance imaging (MRI). This study aimed to analyze MRI data, utilized as a triage test before prostate biopsy, to identify independent risk factors affecting negative biopsy results in PCa and investigate the ability of these factors to predict clinically significant and insignificant PCa (csPCa and ciPCa, respectively).

MATERIALS AND METHODS: A retrospective analysis was conducted on data from 364 patients with a prostate imaging reporting and data system (PI-RADS) v2.1 score of 3 or higher, who underwent cognitive MRI-targeted biopsy (MRI-TB). Of the patients, 226 (62.1%) had benign lesions, 75 (20.6%) were diagnosed with ciPCa, and 63 (17.3%) with csPCa. The study assessed patients' demographic, biochemical, and radiologic characteristics, including apparent diffusion coefficient (ADC) and ADC coefficient of variation (ADCCoV) values.

RESULTS: The multivariate analysis performed to differentiate PCa from benign pathologies revealed that only MRI parameters, specifically the presence of PI-RADS 4 and 5 lesions (odds ratio [OR]: 12, p < 0.001 and OR: 73, p = 0.008, respectively), a lower ADC value (OR: 0.996, p = 0.041) and a higher ADCCoV value (OR: 1.07, p = 0.003) were independent risk factors. No MRI findings had significant predictive power for csPCa, with total prostate-specific antigen (PSA) (OR: 1.17, p = 0.019) found to be the only independent risk factor.

CONCLUSION: The results of this study suggest that data obtained from MRI can predict PCa but not csPCa.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Erkan A, Gur Ozcan SG, Erkan M, et al. Predictive ability of magnetic resonance imaging (MRI) for detecting prostate cancer and its clinical significance in MRI-targeted biopsy for prostate imaging reporting and data system (PI-RADS) ≥3 lesions. Clin Radiol. 2024. PMID: 39536595. doi:10.1016/j.crad.2024.10.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。